Abstract:The diverse inflammatory response found in the liver of patients with autoimmune hepatitis (AIH) is well established, but identification of potentially pathogenic subpopulations has proven enigmatic. We report herein that CD69+CD103+CD8+ TRM cells are significantly increased in the liver of patients with AIH compared to chronic hepatitis B, nonalcoholic fatty liver disease and healthy control tissues. In addition, there was a significant statistical correlation between elevation of CD8+ TRM cells and AIH disease severity. Indeed, in patients with successful responses to immunosuppression, the frequencies of such hepatic CD8+ TRM cells decreased significantly. CD69+CD8+and CD69+CD103+CD8+T cells also known as CD8+ TRM cells, reflect tissue residency and are well known to provide intense immune antigenic responses. Hence, it was particularly interesting that patients with AIH also manifest an elevated expression of IL‐15 and TGF‐β on inflammatory cells, and extensive hepatic expression of E‐cadherin; these factors likely contribute to the development and localization of CD8+ TRM cells. Based upon these data and, in particular, the relationships between disease severity and CD8+ TRM cells, we studied the mechanisms involved with glucocorticoid modulation of CD8+ TRM cell expansion. Our data reflect that glucocorticoids in vitro inhibit the expansion of CD8+ TRM cells induced by IL‐15 and TGF‐β and with direct down‐regulation of the nuclear factor Blimp1 of CD8+ TRM cells. In conclusion, our data suggest CD8+ TRM cells play a critical role in the pathogenesis of AIH, and glucocorticoids attenuate hepatic inflammation through direct inhibition of CD8+ TRM cell expansion.

Chinese Medicine Bu Xu Hua Yu Recipe for the Regulation of Treg/Th17 Ratio Imbalance in Autoimmune Hepatitis

[Effect of Yangyin Yiqi Huoxue Recipe on Immune Balance of Th1/Th2 in Serum and Submaxillary Glands of NOD Mice with Sjogren's Syndrome].

The Imbalance Between Foxp3(+)Tregs and Th1/Th17/Th22 Cells in Patients with Newly Diagnosed Autoimmune Hepatitis

IL-17 Imbalance Promotes the Pyroptosis in Immune-Mediated Liver Injury Through STAT3-IFI16 Axis.

The significance of hepatic regulatory T cells in patients with autoimmune hepatitis

Lamina Propria Interleukin 17 A Aggravates Natural Killer T-cell Activation in Autoimmune Hepatitis

TPN10466 ameliorates Concanavalin A-induced autoimmune hepatitis in mice via inhibiting ERK/JNK/p38 signaling pathway

[Cd4+cd25+high Regulatory T Cells in Patients with Autoimmune Hepatitis].

Interleukin-17 Contributes to the Pathogenesis of Autoimmune Hepatitis Through Inducing Hepatic Interleukin-6 Expression.

Pien Tze Huang alleviates Concanavalin A-induced autoimmune hepatitis by regulating intestinal microbiota and memory regulatory T cells

Xiao-Chai-Hu Tang in Treating Model Mice with D-galactosamine-induced Liver Injury.

Silencing of aryl hydrocarbon receptor repressor restrains Th17 cell immunity in autoimmune hepatitis

1,25(OH) 2 D 3 -Treated Mouse Bone Marrow-Derived Dendritic Cells Alleviate Autoimmune Hepatitis in Mice by Improving TFR/TFH Imbalance

Serum Levels of IL-33 and Correlation with IL-4, IL-17A, and Hypergammaglobulinemia in Patients with Autoimmune Hepatitis

The Clinical Significance of Hepatic CD69 + CD103 + CD8 + Resident‐Memory T Cells in Autoimmune Hepatitis

STAT3-Dependent Effects of Polymeric Immunoglobulin Receptor in Regulating Interleukin-17 Signaling and Preventing Autoimmune Hepatitis

Exploration the Significance of Tfh and Related Molecules on C57BL/6 Mice Model of Experimental Autoimmune Hepatitis

Integrated Bioinformatic Analysis Revealed Biological Processes and Immune Cells Implicated in Autoimmune Hepatitis

Tim‐3 suppresses autoimmune hepatitis via the p38/MKP‐1 pathway in Th17 cells

Fecal microbiota transplantation regulates TFH/TFR cell imbalance via TLR/MyD88 pathway in experimental autoimmune hepatitis

B Cells Expressing CD11b Effectively Inhibit CD4+ T-cell Responses and Ameliorate Experimental Autoimmune Hepatitis in Mice.